These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 9135032)

  • 1. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).
    Penning TD; Talley JJ; Bertenshaw SR; Carter JS; Collins PW; Docter S; Graneto MJ; Lee LF; Malecha JW; Miyashiro JM; Rogers RS; Rogier DJ; Yu SS; AndersonGD ; Burton EG; Cogburn JN; Gregory SA; Koboldt CM; Perkins WE; Seibert K; Veenhuizen AW; Zhang YY; Isakson PC
    J Med Chem; 1997 Apr; 40(9):1347-65. PubMed ID: 9135032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles.
    Almansa C; Alfón J; de Arriba AF; Cavalcanti FL; Escamilla I; Gómez LA; Miralles A; Soliva R; Bartrolí J; Carceller E; Merlos M; García-Rafanell J
    J Med Chem; 2003 Jul; 46(16):3463-75. PubMed ID: 12877584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives.
    Shin SS; Byun Y; Lim KM; Choi JK; Lee KW; Moh JH; Kim JK; Jeong YS; Kim JY; Choi YH; Koh HJ; Park YH; Oh YI; Noh MS; Chung S
    J Med Chem; 2004 Feb; 47(4):792-804. PubMed ID: 14761182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
    Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
    Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation.
    Singh SK; Vobbalareddy S; Kalleda SR; Rajjak SA; Casturi SR; Datla SR; Mamidi RN; Mullangi R; Bhamidipati R; Ramanujam R; Akella V; Yeleswarapu KR
    Org Biomol Chem; 2004 Sep; 2(17):2442-50. PubMed ID: 15326524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation.
    Pal M; Madan M; Padakanti S; Pattabiraman VR; Kalleda S; Vanguri A; Mullangi R; Mamidi NV; Casturi SR; Malde A; Gopalakrishnan B; Yeleswarapu KR
    J Med Chem; 2003 Sep; 46(19):3975-84. PubMed ID: 12954051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
    Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New celecoxib derivatives as anti-inflammatory agents.
    Szabó G; Fischer J; Kis-Varga A; Gyires K
    J Med Chem; 2008 Jan; 51(1):142-7. PubMed ID: 18072726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,3-Diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors.
    Black WC; Brideau C; Chan CC; Charleson S; Chauret N; Claveau D; Ethier D; Gordon R; Greig G; Guay J; Hughes G; Jolicoeur P; Leblanc Y; Nicoll-Griffith D; Ouimet N; Riendeau D; Visco D; Wang Z; Xu L; Prasit P
    J Med Chem; 1999 Apr; 42(7):1274-81. PubMed ID: 10197970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, synthesis and characterization of impurities in celecoxib, a COX-2 inhibitor.
    Satyanarayana U; Rao DS; Kumar YR; Babu JM; Kumar PR; Reddy JT
    J Pharm Biomed Anal; 2004 Jun; 35(4):951-7. PubMed ID: 15193741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors.
    Beswick P; Bingham S; Bountra C; Brown T; Browning K; Campbell I; Chessell I; Clayton N; Collins S; Corfield J; Guntrip S; Haslam C; Lambeth P; Lucas F; Mathews N; Murkit G; Naylor A; Pegg N; Pickup E; Player H; Price H; Stevens A; Stratton S; Wiseman J
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5445-8. PubMed ID: 15454242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties.
    Menozzi G; Merello L; Fossa P; Mosti L; Piana A; Mattioli F
    Farmaco; 2003 Sep; 58(9):795-808. PubMed ID: 13679172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor.
    Harris RR; Black L; Surapaneni S; Kolasa T; Majest S; Namovic MT; Grayson G; Komater V; Wilcox D; King L; Marsh K; Jarvis MF; Nuss M; Nellans H; Pruesser L; Reinhart GA; Cox B; Jacobson P; Stewart A; Coghlan M; Carter G; Bell RL
    J Pharmacol Exp Ther; 2004 Dec; 311(3):904-12. PubMed ID: 15277581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents.
    Khanna IK; Weier RM; Yu Y; Xu XD; Koszyk FJ; Collins PW; Koboldt CM; Veenhuizen AW; Perkins WE; Casler JJ; Masferrer JL; Zhang YY; Gregory SA; Seibert K; Isakson PC
    J Med Chem; 1997 May; 40(11):1634-47. PubMed ID: 9171873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2.
    Khanna IK; Weier RM; Yu Y; Collins PW; Miyashiro JM; Koboldt CM; Veenhuizen AW; Currie JL; Seibert K; Isakson PC
    J Med Chem; 1997 May; 40(11):1619-33. PubMed ID: 9171872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
    Gierse JK; Zhang Y; Hood WF; Walker MC; Trigg JS; Maziasz TJ; Koboldt CM; Muhammad JL; Zweifel BS; Masferrer JL; Isakson PC; Seibert K
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1206-12. PubMed ID: 15494548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methanesulfonamide group at position-4 of the C-5-phenyl ring of 1,5-diarylpyrazole affords a potent class of cyclooxygenase-2 (COX-2) inhibitors.
    Singh SK; Vobbalareddy S; Shivaramakrishna S; Krishnamraju A; Rajjak SA; Casturi SR; Akhila V; Rao YK
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1683-8. PubMed ID: 15026050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.